These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35911888)

  • 1. Case Report: Effect of Targeted Therapy With Carbamazepine in KCNQ2 Neonatal Epilepsy.
    Dilena R; Mauri E; Di Fonzo A; Bana C; Ajmone PF; Rigamonti C; Catenio T; Gangi S; Striano P; Fumagalli M
    Front Neurol; 2022; 13():942582. PubMed ID: 35911888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive Amplitude-Integrated EEG Ictal Pattern and Targeted Therapy with Carbamazepine in KCNQ2 and KCNQ3 Neonatal Epilepsy: A Case Series.
    Vilan A; Grangeia A; Ribeiro JM; Cilio MR; de Vries LS
    Neuropediatrics; 2024 Feb; 55(1):32-41. PubMed ID: 37827512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
    Vilan A; Mendes Ribeiro J; Striano P; Weckhuysen S; Weeke LC; Brilstra E; de Vries LS; Cilio MR
    Neonatology; 2017; 112(4):387-393. PubMed ID: 28926830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and safe response to low-dose carbamazepine in neonatal epilepsy.
    Sands TT; Balestri M; Bellini G; Mulkey SB; Danhaive O; Bakken EH; Taglialatela M; Oldham MS; Vigevano F; Holmes GL; Cilio MR
    Epilepsia; 2016 Dec; 57(12):2019-2030. PubMed ID: 27888506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early recognition of characteristic conventional and amplitude-integrated EEG patterns of seizures in SCN2A and KCNQ3-related epilepsy in neonates.
    Pijpers JA; Au PYB; Weeke LC; Vein AA; Smit LS; Vilan A; Jacobs E; de Vries LS; Steggerda SJ; Cilio MR; Carapancea E; Cornet MC; Appendino JP; Peeters-Scholte CMPCD
    Seizure; 2023 Aug; 110():212-219. PubMed ID: 37429183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and effective treatment of KCNQ2 encephalopathy.
    Pisano T; Numis AL; Heavin SB; Weckhuysen S; Angriman M; Suls A; Podesta B; Thibert RL; Shapiro KA; Guerrini R; Scheffer IE; Marini C; Cilio MR
    Epilepsia; 2015 May; 56(5):685-91. PubMed ID: 25880994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective study on neonatal seizures in a tertiary center of northern Italy after ILAE classification: Incidence, seizure type, EEG and etiology.
    Dilena R; Molisso MT; De Carli A; Mauri E; Circiello A; Di Benedetto A; Pisoni S; Bassi L; Bana C; Cappellari AM; Consonni D; Mastrangelo M; Granata T; La Briola F; Peruzzi C; Raviglione F; Striano P; Barbieri S; Mosca F; Fumagalli M
    Epilepsy Behav; 2024 Oct; 159():109971. PubMed ID: 39094245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic analysis of 18 patients with
    Cao B; Peng B; Tian Y; Wang X; Li X; Zhu H; Shen H; Chen W
    Turk J Pediatr; 2024 May; 66(2):191-204. PubMed ID: 38814296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of KCNQ2 encephalopathy.
    Kim HJ; Yang D; Kim SH; Won D; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2021 Feb; 43(2):244-250. PubMed ID: 32917465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation.
    Kato M; Yamagata T; Kubota M; Arai H; Yamashita S; Nakagawa T; Fujii T; Sugai K; Imai K; Uster T; Chitayat D; Weiss S; Kashii H; Kusano R; Matsumoto A; Nakamura K; Oyazato Y; Maeno M; Nishiyama K; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Saito K; Hayasaka K; Matsumoto N; Saitsu H
    Epilepsia; 2013 Jul; 54(7):1282-7. PubMed ID: 23621294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridoxine-responsive KCNQ2 epileptic encephalopathy: Additional cases and literature review.
    Chen J; Tao Q; Fan L; Shen Y; Liu J; Luo H; Yang Z; Liang M; Gan J
    Mol Genet Genomic Med; 2022 Oct; 10(10):e2024. PubMed ID: 35906921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal presentation of genetic epilepsies: Early differentiation from acute provoked seizures.
    Cornet MC; Morabito V; Lederer D; Glass HC; Ferrao Santos S; Numis AL; Ferriero DM; Sands TT; Cilio MR
    Epilepsia; 2021 Aug; 62(8):1907-1920. PubMed ID: 34153113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pearls & Oy-sters: Genetic Epilepsy: An Important Cause of Neonatal Seizures in Infants With Complex Congenital Heart Disease.
    Kazazian V; Selvanathan T; Chau V; Tam EWY; Miller SP
    Neurology; 2022 Oct; 99(18):811-814. PubMed ID: 36041864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy.
    Dilena R; Striano P; Gennaro E; Bassi L; Olivotto S; Tadini L; Mosca F; Barbieri S; Zara F; Fumagalli M
    Brain Dev; 2017 Apr; 39(4):345-348. PubMed ID: 27876397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pointed rhythmic theta waves: a unique EEG pattern in KCNQ2-related neonatal epileptic encephalopathy.
    Buttle SG; Sell E; Dyment D; Bulusu S; Pohl D
    Epileptic Disord; 2017 Sep; 19(3):351-356. PubMed ID: 28832002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance.
    Zara F; Specchio N; Striano P; Robbiano A; Gennaro E; Paravidino R; Vanni N; Beccaria F; Capovilla G; Bianchi A; Caffi L; Cardilli V; Darra F; Bernardina BD; Fusco L; Gaggero R; Giordano L; Guerrini R; Incorpora G; Mastrangelo M; Spaccini L; Laverda AM; Vecchi M; Vanadia F; Veggiotti P; Viri M; Occhi G; Budetta M; Taglialatela M; Coviello DA; Vigevano F; Minetti C
    Epilepsia; 2013 Mar; 54(3):425-36. PubMed ID: 23360469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2.
    Kearney JA; Yang Y; Beyer B; Bergren SK; Claes L; Dejonghe P; Frankel WN
    Hum Mol Genet; 2006 Mar; 15(6):1043-8. PubMed ID: 16464983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal SCN2A encephalopathy: A peculiar recognizable electroclinical sequence.
    Melikishvili G; Dulac O; Gataullina S
    Epilepsy Behav; 2020 Oct; 111():107187. PubMed ID: 32603808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized tonic seizures with autonomic signs are the hallmark of SCN8A developmental and epileptic encephalopathy.
    Trivisano M; Pavia GC; Ferretti A; Fusco L; Vigevano F; Specchio N
    Epilepsy Behav; 2019 Jul; 96():219-223. PubMed ID: 31174070
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.